Huron Consulting Group Inc.

Q1 2021 Earnings Conference Call

5/4/2021

spk01: Good afternoon, ladies and gentlemen, and welcome to Yvonne's Consulting Groups webcast to discuss financial results for the first quarter 2021. At this time, all conference call lines are on a listen-only mode. Later, we will conduct our question and answer session for conference call participants, and instructions will follow at that time. As a reminder, this conference call is being recorded. Before we begin, I would like to point all of you to the disclosure at the end of the company's news release for information about any forward-looking statements that may be made or discussed on this call. The news release is posted on Neuron's website. Please review that information along with the filings with the SEC. For a disclosure or factors that may impact subjects discussed in this afternoon's webcast, the company will be discussing one or more non-GAAP financial measures. Please look at the earnings release and on Yaron's website for all the disclosures required by the SEC, including reconciliation to the most comparable GAAP numbers. And now, I would like to turn the call over to Jim Roth, Chief Executive Officer of Huron Consulting Group. Mr. Roth, please go ahead.
spk02: Good afternoon and welcome to Huron Consulting Group's first quarter 2021 earnings call. With me today are John Kelly, our Chief Financial Officer, and Mark Hussey, our President and Chief Operating Officer. Our first quarter financial results were in line with our expectations. Revenues declined 9% in the first quarter of 2021 as compared to the same period in the prior year, driven by declines in the healthcare and education segments. Those declines were partially offset by strong growth in the business advisory segment. During the first quarter, we saw an increase in our sales pipeline and the pace of signings in our healthcare and education businesses. which gives us further confidence in our ability to meet our updated full-year performance expectations. As the overall demand for our services has increased during 2021, we now believe we are past the pandemic-driven low watermarks for education and healthcare segment revenues, and we expect sequential growth in these businesses moving forward in 2021. We believe the low point for the education segment occurred in the fourth quarter of 2020, while the low point for the healthcare segment was in the first quarter of 2021. Looking ahead, we see increased demand for our healthcare and education services as our clients prepare for a recovering economic environment, which has also strengthened growth in our business advisory segment. I will now share some additional insight into our first quarter performance. During the first quarter, healthcare segment revenues declined 17% over the prior year first quarter. reflective of the difficult first quarter comparisons driven by the growth we experienced in the segment at the beginning of 2020, prior to the impact of the pandemic. The healthcare business got off to a slower start this year, given the continued disruption of the pandemic and vaccine rollout on our hospital and health system clients. As the quarter progressed, our sales pipeline increased and remained at record levels, and the pace of signings and conversion to hard backlog also improved each month. Assessments for our performance improvement offerings have continued to grow, and in April, assessment volume neared pre-pandemic levels. As hospitals and health systems plan for a post-pandemic future, many organizations are prioritizing several key initiatives. Among the most important priorities is making care more affordable while also providing greater price transparency to consumers. As we look at our pipeline, market demand is focused on our core performance improvement and managed services offerings to address near-term financial pressures. In addition, we are seeing substantial demand for one of our newest offerings, which was developed collaboratively across our healthcare, strategy, and technology businesses. This offering helps health systems achieve structural changes to ensure the sustainability of their business model in the future. Given the near-term financial challenges and long-term growth aspirations of our clients, we believe our collective performance improvement-related offerings will continue to be an ongoing source of growth for our business. A second priority for healthcare providers is accelerating care transformation strategies to deliver a substantially greater amount of care virtually, including through telehealth, remote patient monitoring, and hospital-at-home models. The pandemic has highlighted the need for providers to formalize their long-term virtual care strategies and build the right consumer-centric infrastructure to support patients throughout their care journey. The breadth of our care delivery organizational transformation and digital technology and analytics offerings and deep expertise in implementing telehealth and hospital-at-home models positions Chiron to add significant value to our clients as they establish and implement their care transformation. The third priority among our healthcare clients is focusing on enhancing the digitization and use of clinical and operational data with a strong emphasis on planning and analytics. Many healthcare organizations are making significant investments in their administrative operations, comparable to some of the investments in clinical systems that have been made over the past decade. Once again, our healthcare business is well positioned to help our clients navigate this next wave of digital transformation. The growth of our healthcare pipeline and the pace of signings in recent months are indications that our offerings are resonating well with our client base as they seek assistance in addressing these key priorities. Turning to the business advisory segment, in the first quarter of 2021, business advisory segment revenues grew 12% over the prior year quarter, 9% organically, driven by strong, broad-based demand across our strategy, digital technology and analytics, and distress advisory offerings. As we've discussed on prior calls, we continue to execute on our commercial strategy, which is aimed at going to market collaboratively across the four businesses in this segment. The business advisory segment has grown revenues at a compound annual growth rate of 15% over the last five years, inclusive of the recent pandemic era, which reinforces the importance of this segment to our company's growth strategy. When looking beyond the numbers, you will find several important attributes of that revenue growth that bode well for the future of this segment. First, we are winning sizable projects among numerous Fortune 500 companies, particularly in energy and utilities, financial services, industrials and manufacturing, and life sciences. Second, we continue to capitalize on one of our greatest strategic advantages by integrating our deep industry and functional expertise with our strong strategy, technology, and operations capabilities. Coupled with our nimble approach to serving our clients from strategy through execution, Our expertise and experience allow us to compete and win against larger competitors. We are in the process of building additional competencies that will further position the segment for above-average growth in the coming years. In addition, our digital technology and analytics offerings continue to provide the foundation for growth in the commercial sector, and our distressed advisory services continue to perform well amidst the many financial challenges impacting middle market companies. We are also seeing solid demand for our strategy and innovation services as the economy continues to recover. Turning now to the education segment, in the first quarter of 2021, education segment revenues declined 19% over the prior year quarter, reflective of the difficult first quarter comparisons driven by the strong growth we experienced in this segment at the beginning of 2020 prior to the impact of the pandemic. Sequentially, education segments revenues grew 7% over the fourth quarter of 2020, driven by strong demand in our research, strategy, and operations offerings. Similar to healthcare, as the quarter progressed, our sales pipeline increased across our offerings and the pace of signings improved month over month. While some of the larger ERP-related engagements continue to be delayed, the pipeline of opportunities is widening and many institutions are beginning to feel more comfortable that they have the bandwidth and financial stability to undertake these significant projects. We have also seen smaller institutions moving ahead with their digital transformation, giving greater visibility into their financial position. While some higher education institutions face sizable COVID-19-related losses, others have found the losses to be less than initially anticipated. in part due to financial support by the federal government. Many colleges and universities are now more aggressively evaluating how to be successful in a post-pandemic environment, including trying to establish more sustainable operating models. These attributes will continue to drive demand for our broad set of offerings in this segment. Before I turn to our outlook for the year, I'd like to add several comments about our collective technology capabilities. As I mentioned last quarter, our technology services grew to over 30% of total company revenues in 2020. Technology has become an increasingly important pillar of growth for this company and is deeply embedded in each of our segments. We continue to grow our teams in North America as well as in India to support the market demand for these offerings. Finally, let me turn to our outlook for the year. Historically, we have not adjusted our annual guidance after the first quarter. Today, the signs of recovery in our healthcare and education businesses and continued momentum in the business advisory segment give us confidence to raise and narrow our full year guidance. As our press release indicates, we are increasing and narrowing our annual revenue guidance to $850 to $900 million. We are also maintaining our adjusted EBITDA guidance in a range of 10.8% to 11.8% of revenues and increasing our adjusted diluted earnings per share in a range of $2.35 to $2.75. We raised our revenue guidance to reflect the current and anticipated demand for our services across all segments. We continue to anticipate modest sequential revenue growth in the first half of the year as compared to the second half of 2020, followed by stronger growth in the second half of 2021. We are also investing for the long term, further expanding our capabilities in areas we believe have strong growth potential given current market dynamics, including our healthcare managed services and our digital technology and analytics offerings across all of our segments. We are focused on our financial strategy of achieving sustainable organic revenue growth and expanding margins over time, And we continue to believe our business will generate mid to upper single digit growth over the medium term. The disruption facing our clients and primary end markets is substantial, stemming from the impacts of the COVID-19 pandemic, as well as the rapidly evolving competitive landscape. And we believe this disruption creates significant opportunities for growth in our business. Before I turn it over to John, let me make two final comments. First, I want to recognize the challenge that our Indian colleagues are facing given the recent surge in COVID-19 cases. We are working closely with our country leadership team to support our people and their loved ones, as well as the local community, and have executed our business continuity plans to minimize the disruption to our business. Lastly, I want to thank our entire team for all they have done during the pandemic. They have demonstrated an incredible amount of agility and creativity while also remaining focused on supporting our clients, our company, and each other. Now let me turn it over to John for a more detailed discussion of our financial results. John?
spk03: Thank you, Jim, and good afternoon, everyone. Before I begin, please note that I will be discussing non-GAAP financial measures, such as EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and free cash flow. Our press release, Thank You, and investor relations page on the Huron website have reconciliations of these non-GAAP measures to the most comparable GAAP measures, along with a discussion of why management uses these non-GAAP measures and why management believes they provide useful information to investors regarding our financial condition and operating results. Also, unless otherwise stated, my comments today are all on a continuing operations basis. Also, our acquisition of Unico Solution, which closed on February 1st, is included in our first quarter financial results in the business advisory segment, subsequent to the acquisition date. Now, let me walk you through some of the key financial results of the quarter. Revenues for the first quarter of 2021 were $203.2 million, down 8.7% from $222.6 million in the same quarter of 2020. The decline in revenues in the quarter was driven by the healthcare and education segments, which faced challenging pre-pandemic year-over-year comparisons in the first quarter of 2021. This decline was partially offset by continued growth in the business advisory segment. Net income was $5.4 million, or 24 cents per diluted share, in the first quarter of 2021, compared to net loss of $42.3 million, or $1.94 per diluted share, in the same quarter in the prior year, which was inclusive of the $59.8 million pretax goodwill impairment charge taken in the first quarter of 2020. Our effective income tax expense rate in the first quarter of 2021 was 22.1 percent compared to 21 percent benefit rate one year ago. Our effective tax rate for Q1 of 2021 was more favorable than the statutory rate, inclusive of state income taxes, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2021. This favorable tax benefit was partially offset by certain non-deductible expenses. Adjusted EBITDA was $16.5 million in Q1 2021, or 8.1 percent of revenues, compared to $19 million in Q1 of 2020, or 8.5 percent of revenues. Adjusted non-GAAP net income was $7.8 million or 35 cents per diluted share in the first quarter of 2021 compared to $9.8 million or 44 cents per diluted share in the same period of 2020. Now I'll make a few comments about the performance of each of our operating segments. The healthcare segment generated 39% of total company revenues during the first quarter of 2021. This segment posted revenues of $79.7 million for the first quarter of 2021, down $15.9 million, or 16.6% from the first quarter of 2020. The decline in revenue reflects the ongoing impact of the COVID-19 pandemic in the first quarter of this year, relative to a quarter that was largely unimpacted by COVID-19 last year. As Jim mentioned, we believe the first quarter of 2021 will be the revenue low point for this segment related to the pandemic as we expect sequential revenue growth moving forward in 2021, reflecting the ongoing recovery of the healthcare industry. Operating income margin for healthcare was 25.7% for Q1 of 2021 compared to 25.2% for the same quarter in 2020. The quarter-over-quarter increase in margin was primarily attributable to decreases in conference-related expenses performance bonus and share-based compensation expense, and promotion and marketing expenses, largely offset by an increase in salaries and related expenses for our revenue-generating professionals as a percentage of revenues, reflecting lower utilization. As a reminder, our first quarter results included the annual resetting of our wage basis for certain fringe items like the employer portion of FICA taxes and our 401 match. As Jim mentioned, we continue to invest in areas of our business that align with our enterprise strategy, including managed services. In April, we hired approximately 300 healthcare professionals to expand our managed services capacity to provide revenue cycle billing, collections, insurance verification, and charge integrity services to our healthcare clients. While we expect revenue of around $10 million during 2021 related to this group hire, We only expect modest accretion from an earnings perspective as we invest to build out our capabilities for future growth. The business advisory segment generated 36 percent of total company revenues during the first quarter of 2021. Segment posted revenues of $72.9 million in Q1 2021, up $8 million, or 12.3 percent, from the first quarter of 2020. Revenues for the first quarter of 2021 include $2.4 million from our acquisitions of ForceIQ and Unico Solution. Our organic revenue growth rate in the business advisory segment was 9% for the quarter. The quarter-over-quarter increase in revenue was broad-based across our strategy, digital technology and analytics, and distressed advisory offerings. The operating income margin for the business advisory segment was 17.9% for Q1 of 2021, compared to 15.2% for the same quarter in 2020. The quarter-over-quarter increase in margin was primarily due to increases and decreases, rather, in restructuring charges and promotion and marketing expenses, partially offset by an increase in performance bonus expense for our revenue-generating professionals. The education segment generated 25% of total company revenues during the first quarter of 2021. The segment posted revenues of $50.6 million in Q1 2021, down $11.5 million, or 18.5% from the first quarter of 2020. The decline in revenue reflects the ongoing impact of the COVID-19 pandemic as compared to a quarter that was largely unimpacted by the pandemic in 2020. The education segment grew 7% sequentially in the first quarter of 2021 over the fourth quarter of 2020. And as Jim mentioned, we believe the fourth quarter of 2020 will be the revenue low point for this segment related to the pandemic, as we expect sequential revenue growth moving forward in 2021, reflecting the ongoing recovery of the higher education industry. The operating income margin for education was 17.1%. for Q1 of 2021 compared to 21.1% for the same quarter in 2020. The quarter-over-quarter decline in margin was primarily due to a decrease in utilization, partially offset by decreases in contractor expense, promotion and marketing expense, and performance bonuses expense for our revenue-generating professionals. Other corporate expenses not allocated at the segment level were $28.8 million in Q1 2021 compared with $27.1 million in Q1 of 2020. Unallocated corporate expenses in the first quarter of 2021 include $800,000 of expense related to the increase in liability to participants in our deferred compensation plan, which is fully offset by the corresponding gain in other income related to the increase in value of the assets used to fund this plan. Conversely, unallocated corporate expenses in the first quarter of 2020 reflected a reduction of expense of $4.7 million related to our deferred compensation plan. Absent the impact of our deferred compensation plan in both periods, the $3.8 million decrease in unallocated corporate costs reflects decreased stock compensation and salaries and related costs for our support personnel, decreased practice administration and meeting expenses, and decreased training expenses as well as recruiting expenses. Now turning to the balance sheet and cash flows. DSO came in at 64 days for the first quarter of 2021 compared to 52 days for the fourth quarter of 2020 and 62 days for the first quarter of 2020. We expect DSO to normalize to around 60 days over the course of 2021. Total debt includes the $265 million in senior bank debt and a $3 million promissory note for total debt of $268 million. We finished the quarter with cash of $22 million for net debt of $246 million. This was a $110 million increase compared to Q4 of 2020, as the first quarter reflects the payment of our annual bonuses. The first quarter also included $11.5 million of share repurchases under our $50 million board authorization, $8.5 million of shares redeemed to satisfy employee tax withholdings related to our share-based compensation program, and $6 million related to business acquisitions. Our leverage ratio, as defined in our senior bank agreement, was approximately 2.6 times adjusted EBITDA as of March 31st, 2021, compared to 3.5 times adjusted EBITDA at the end of Q1 2020. The first quarter of 2020 leverage reflects borrowings of $125 million on a revolving line of credit out of an abundance of caution at the outset of the COVID-19 pandemic. Our net leverage ratio was 2.4 times trailing 12 months adjusted EBITDA as of March 31st, 2021 when the bank definition calculation is adjusted for cash on hand. This compares to 2.3 times trailing 12 months adjusted EBITDA as of March 31st, 2020 when calculating in the same manner. Cash flow used in operations in the first quarter of 2021 was $83 million. We used $2 million of our cash to invest in capital expenditures, inclusive of internally developed software costs, resulting in free cash flow of negative $85 million. Finally, let me turn to our expectations and guidance for 2021. As Jim noted, we are raising and narrowing our full-year 2021 revenue guidance to $850 million to $900 million. The increase in our revenue guidance primarily reflects the ongoing momentum in our business advisory segment and better visibility and increased confidence that we have progressed past the revenue low points related to our healthcare and education segments. In addition, we are forming our full year adjusted EBITDA guidance to be in a range of 10.8% to 11.8% of revenues. And we are increasing our full year adjusted non-GAAP diluted earnings per share guidance to be in a range of $2.35 to $2.75. Finally, we expect our full-year effective tax rate to be in a range of 26% to 29%. Thanks, everyone. I would now like to open the call up to questions. Operator?
spk01: Thank you. And ladies and gentlemen, if you have a question at this time, please press the star 1 key on your touchtone telephone. If your question has been answered or you wish to remove yourself from the queue, you may do so by pressing the pound key. One moment for our first question, please. Our first question comes from Toby Sommer of Truist Securities. Your line is open.
spk07: Thank you. With respect to the education and healthcare businesses, I was wondering if you could comment on what the pipeline looks like from a project size and complexity perspective as you work your way through the year and maybe juxtapose that with different ranges of small versus large size historically. Thank you.
spk02: Toby, this is Jim. I'll start. I think a lot of things I think are beginning to look a little bit like they did toward the end of 2019. I think in terms of size and complexity, we're going to have a mix of, you know, decent-sized large systems projects. We're going to always have strategy projects that tend to go a little bit in the middle. And, of course, research and student are doing very well. So I think the composition of the pipeline is going to look fairly similar to what it was before. I think what we witnessed, particularly early in 2020, and through a lot of 2020 was scaling back from a lot of clients in terms of the size, just because they weren't sure of the bandwidth. They weren't sure if there was going to be other disruptions. But I think we're beginning to see the pipeline begin to resemble what it looked like prior to COVID in terms of size and complexity. John, anyone want to add to that?
spk03: You know, Jim, I think I agree with what you said. I think the only thing that I would add is in the education segment, I think in terms of the research parts of our business, as well as the strategy part of the business, I think the pipeline, as Jim said, is definitely, we definitely have line of sight to kind of pre-COVID levels in both parts of, or those two parts of the business. I'd say for the larger admin system replacement projects or the student system replacement projects, we're certainly seeing opportunities in the market. And in the long run, We're highly confident that that's a very big addressable market for us and a place where we're very well positioned. But in the short term, just because of the sheer size of some of those projects, I think that's probably not quite back to pace yet with the pre-COVID levels on some of those bigger ones. But that's something that obviously there are opportunities out there and that we plan on positioning ourselves well as the year goes on in that part of the market.
spk07: Thank you. Could you give us a sense for your hiring posture for internal full-time staff and maybe a little bit more color about that group hire?
spk03: Sure, I can start on that. From a hiring perspective, I'd say, you know, as we start to have better visibility into the back half of the year and we've seen some of the conversion of the pipeline and some of the opportunities that we've had since the beginning of the year. I think that we have been getting more aggressive from a hiring perspective. If I take it kind of segment by segment in the healthcare segment, as you know, our target utilization in that part of the business tends to be in the higher 70s, and we finished the first quarter more in the 68% range. So I think we still have some room from a utilization perspective there. Though we are still making strategic hires, we're probably... not adding a ton of capacity at this point just based on some of the capacity we have in our current workforce. On the education side, I'd say there in certain parts of the business have rebounded strongly. I think that we, you do see us getting more aggressive in terms of the hiring within the education part of the business. They had some nice sequential growth in the first quarter versus the fourth quarter. you know, and based on our projections for the rest of the year, I think that we expect utilization to tighten up as the year goes on and for the need to expand. And then in the business advisory segment, you know, that segment's been growing at a nice pace really throughout the pandemic, and we've been hiring throughout the pandemic as well. And our expectation is that that trend will continue as the year goes on.
spk07: And last question from me, and I'll get back in the queue. Could you talk about either headwinds or tailwinds that had been created out of the many kind of factual appropriations out of Washington and or the sort of prospective ones. I think there was some comment about basic research in the infrastructure-related bill that maybe could play into your education space. So I wanted to get your perspective there, too.
spk02: Toby, Jim, are you talking about health care or education or both?
spk07: Both, because there's so many different appropriations that have factually kind of come out of D.C. and several more sort of in the works.
spk02: Yeah. Well, so I'll make a couple comments. I think, first of all, I think in both cases in health and education, I think a lot of our clients certainly took a hit in, I think in the end, by the way, I don't want to be presumptuous and assume that this is the end, but at this stage, I think some of the losses that they initially thought were going to happen aren't going to be as severe. It doesn't mean the losses weren't tough, but a lot of them I think are ending up 14 months after the pandemic started are probably in better shape than their worst fears earlier in the pandemic. So I think that's likely to be a little bit of a tailwind for us I think in terms of the appropriations, particularly around health care, I mean, I'm sorry, particularly around research, I think they're generally very good. This administration seems to be very supportive of research, so that should also work out well. I think some of the question marks will be around kind of what happens with respect to reimbursement, particularly around Medicare and Medicaid, and whether there ends up being any state for public universities, whether there ends up being any – assistance from the state and local governments in terms of providing support, that remains a question mark, I think. But in general, I think a lot of our clients are positioned now better than they thought they would be, say, seven, eight, nine months ago. And so I think in general, those are the tailwinds that we're seeing, and I think that's probably the reason that we're seeing the pipeline build up to what we have, because I think they're beginning to realize that they now have a little bit more confidence in their own future sustainability and their own ability to accomplish what they want to accomplish. Thank you.
spk01: Our next question comes from Andrew Nicholas of William Blair. Please proceed, sir.
spk00: Thank you. Good afternoon. I wanted to ask a follow-up on the hiring environment. I appreciate your color on kind of segment level expectations. But could you maybe speak to the competitiveness of finding talent right now? It seems like there's a lot of your competitors who have similar ideas in terms of adding headcount. And I'm just wondering, you know, how you kind of take that into account when you're thinking about, you know, building into demand later on this year. Yeah.
spk02: Andrew, this is Jim. I think it's fair to say that the hiring environment has become more competitive. In part, it's competitive among our competitors, our natural competitors. In part, it's competitive across kind of other industries and people just looking to do different things. There's certainly, particularly around technology and other areas, there's a lot of growth. And so I think as the economy accelerates quickly, you're going to find I think a lot of organizations are going to be hiring. So We do find it to be a more competitive environment. I think our ability to recruit is actually quite good. I think we kind of – and I don't say this lightly, but I think we really have a very strong culture into which to recruit. People know that. People have heard that among their colleagues and friends, and so that gives us a real benefit. But it is a more difficult environment in which to – just more competitive environment rather, that we're dealing with right now. And so I think at the same time, you know, there may be some people that want to make a transition. The part that I think that we're somewhat focused on right now is that if you had gone back over the last decade or two decades and you said what was the hardest part about consulting in terms of recruiting, it would be the expectations for a heavy dose of travel. And our sense right now, Andrew, is that, I think in most cases, and I'll just throw out a rough number, my guess is in most cases the amount of travel that's going to be required is probably going to be half of what it was, and it may be less. There will be isolated instances where it's more, but it's mostly going to be less. And so you end up having one of the hardest things about consulting, and that's fairly frequent travel, and you reduce it substantially. It creates a much better environment into which to recruit. So we think that's going to be beneficial for us once the kind of COVID impact begins to settle in.
spk00: Perfect. That's helpful. And then for my follow-up, and then I'll get back in the queue, just asking about the pipeline in a different way, just overall visibility across each of the businesses. It seems like, you know, pipeline is building quite nicely. The different segments are having an easier time making decisions. But could you just compare visibility now relative to three months ago when we spoke on the fourth quarter call and how – either of those compares to kind of the summer months. I'm just trying to get a sense for even if something isn't in the pipeline, how quickly you would expect those decisions to become more rapid. Thank you.
spk03: I would say I could take the first step at that. You know, if I look across the business and I start with our healthcare segment, I think the difference probably over the past three months is certainly our clients have been impacted by what's happened over the past year and even before that it was a challenging environment for many of our clients. And so we saw a lot of those opportunities in the pipeline. We've been having a lot of good conversations and I think probably the progression from where we were a quarter ago is really towards the back end of the first quarter and then even into the month of April. We had conversion on some of those opportunities and some of those projects that we think are going to be you know, very nice projects for us as the year progresses and to help get us back in our growth trajectory. I think in addition to that, one of the things that we always look at is our volume of assessment activities. So that's clients that come to us who have issues from either a financial and operating perspective and, you know, bring us in to assess the opportunity to help them and The volume of those assessment activities within healthcare is within line of sight, again, of kind of where we were pre-COVID-19. So we feel like that's another key indicator for us that there's a number of projects that are in the pipeline. And then we've been building out our managed service offerings as well over the course of the past year. And that's another area where we're just seeing a lot of interest from our clients. And they're really coming forward to us with opportunities there to help them out. So I'd say that kind of summarizes the healthcare side of it. From an education perspective, I'd say one big difference is we had a really nice quarter of sequential revenue growth off of what was probably the low point in the fourth quarter. Similar to what I would describe in healthcare, I think we've seen a very nice pickup in the pace of conversion of some of those opportunities that we've talked about for the past call or two that were in the pipeline. And that was, whereas some of the healthcare conversions were more, you know, they happen towards the end of the first quarter, the first part of the second quarter. I'd say on the education side of the business, particularly within our research and our strategy offerings, we've seen a lot of those conversions throughout the first quarter. So that's another thing that's given us confidence. And I'd say, zoom in now for a second to both healthcare and education. I'd say just in general, the progress that we've made in the U.S. in terms of the vaccine, And really for a lot of our clients and the leaders that we talked to, those clients kind of the sense that they're able to now start to think more about their strategic priorities and their strategic objectives. I think that that factors in as well. We see a lot of clients coming forward who are starting to rethink about the things that were on their plate before the pandemic hit and they were severely disrupted over the past year. And then finally, from a business advisory perspective, Jim mentioned it in his remarks, On the strategy side of the business, we've seen a nice rebound there. Our technology business continues, quite frankly, to build momentum. That very full suite of technology offerings that we have at this point is resonating very well with our commercial clients as well as clients across the healthcare and education industries. And then the one maybe area that's a little bit different is our distressed business, which actually had a very nice first quarter and posted some nice growth during the first quarter year over year. I would just note that they're up against a couple of tough comps in the second and third quarter, just based on how hot that market was in the second and third quarter. So we still feel good about the pipeline and the opportunities for that business, but it probably will be a challenging couple of quarters of comps here just based on what happened last year.
spk00: Great. Thank you.
spk01: As a reminder, if you have a question at this time, please press the star 1 key on your touchtone telephone. If your question has been answered or you wish to remove yourself from the queue, you may do so by pressing the pound key. Again, if you would like to ask a question, please press star 1. Our next question comes from Kevin Steinke of Barrington. Please proceed, sir.
spk05: Good afternoon. So I think you've touched on this a bit in response to other questions, but maybe just can you talk about why the pipeline in health care and education has continued to move forward and convert maybe a little bit more quickly then you would have expected in your original guidance, you know, perhaps you had kind of built in some more conservative conservatism into that original guidance based on the uncertainty of the situation. But it's just as you talk to, you know, leaders in health care and education, is it just kind of the vaccination rollouts that are really given the confidence to move forward a little more quickly than you'd expect there? You know, what other factors would you highlight there?
spk02: Kevin, this is Jim. I think there's a couple ways of looking at it. I mean, you know, for all of us, this has happened so quickly. And I think if you look at the sequence of events that took place over the last year plus, I mean, we went through that kind of horrific March, April, May timeframe of where healthcare's health systems was kind of completely absorbed in the urgency of a new virus, and education was kind of looking and wondering. Kids had already gone off campus, and they're wondering, are we even going to be able to have kids back in September? But there was still hope that the summer would be better, and part of the summer was better, and that got a lot worse. And so that set things back a little bit in the fall, and then we had that other surge again in December. So our clients have gone through this horrible period, of kind of ups and downs and really trying to guess it. And I think the fact that the vaccines came out in January and have begun to now spread and take hold, I think gives us everybody some more confidence. They can begin to not just kind of do stuff that they actually thought they wanted to do historically, particularly, you know, improving their digital transformations, but at the same time, try to get to the point where they can now be responsive to what in many cases, including education and healthcare, is going to be very different markets coming up shortly. And so that, I think, is why we're seeing this pick up in the pipeline right now and just in terms of their ability to go back and say, okay, so far we've kind of survived this. We can't just go back and assume things are going to resume. We've got to do things differently. So across the board, you know, whether it's care transformation and changes that are taking place there, whether it's telehealth and healthcare, whether it's new business models and education, it's just new strategies that are going to be required to kind of meet a very different environment This is really, it's all across the board, large, small, public, private, any kind of hospital. They're all really kind of looking at this very uncertain future. I think now they're having enough confidence to know that at least as it seems right now, the worst of it's over, and they can now begin focusing on their business. I think in the last 12 months, it was hard to focus on your business when you really thought that there might be another surge coming in a matter of weeks or months. So that, I mean, collectively, it's just kind of a mindset that has enabled people to go back and say, we've got to now take care of our business. I would say, more than anything, those are the factors behind our having a bigger pipeline and greater visibility into that pipeline.
spk05: Okay, great. That's helpful. And also, I wanted to follow up on your discussion of hiring about 300 people people in the managed services area. Is this kind of an outgrowth of that original managed services project you had in healthcare and for a larger client and maybe you've had some success there and does that kind of speak to why you're being able to expand this offering? I just want to see if I could tie that together with, you know, what you had been originally doing in the healthcare arena.
spk03: I think, Kevin, it's clearly a continuation of our strategy as it relates to managed services. We do see the need in the market. We see a number of clients who are very interested in opportunities to improve their operations improve their financial results, and they view managed services with a trusted partner as one way to be able to achieve those objectives. And so we've had a really great partnership on that first project that we talked about. We feel like we've been very successful working with the client there to drive a really positive impact for them, and that you know, has kind of opened the door for more opportunities for us to continue to build out those capabilities and to be thoughtful about how we can continue to build out the team there to meet the demand that we expect to be coming. So it is an offshoot in that regard. Then, you know, we think that the 300 that we've hired, quite frankly, some of the, you know, there are some, there is some specific revenue that will come associated with that group. But there were a number of things in our own pipeline where we really made the determination that bringing these employees on are going to help us execute and most effectively deliver on some of those opportunities that were separately existing in our pipeline. So we're very excited to have them join the team, and I think our viewpoint is it really helps round out our offerings from a managed services perspective in healthcare.
spk05: Okay, great. That's helpful. You talked about also in your prepared comments just how sizable technology has become as part of your offerings and that you're going to continue to invest there. Would technology-focused acquisitions still kind of be at the top of mind when you're thinking about M&A going forward, and are you contemplating when you're talking about investing in your technology offerings, potentially further acquisitions in that space?
spk06: Yeah. Hey, Kevin. This is Mark. I'll address that one. I think the answer is certainly yes. We see continuing opportunities just to fill in what we think is a fairly comprehensive suite of enterprise platform capabilities today, and it's expanded into data and analytics as well. You know, there's definitely opportunities for us just to strengthen various areas, and I think you'll see us continue to be, you know, active where we see opportunities in the marketplace.
spk05: Okay, great. How do you just overall feel like where your capacity stands in terms of, you know, balance sheet to – to pursue your acquisition strategy? I assume you're going to continue to pay down debt here, but maybe John, just talk about debt pay down and where you'd like to get from a leverage perspective.
spk03: Sure, Kevin. To answer your first question, I think we feel very good about our capacity, given the the amount that we have on our revolving line of credit as well as our expected free cash flow for the year. As you know, it's our seasonal high watermark in terms of borrowings just after the annual incentive payments in March. So that's expected. And the default coming out of the first quarter, of course, is to pay down debt. But I think clearly as with that kind of large cash outflow behind us, Given, you know, our expected free cash flow for the rest of the year, we think that gives us plenty of opportunity to both continue to pay down our debt and to get back down, you know, call to the two times level, while also having capacity to repurchase shares to the extent that it's, you know, we think that that's a good opportunity. And clearly, to the extent, you know, we can offset some of the dilution that comes from our share based compensation programs. but as well for strategic tuck-in type M&A. I think our perspective is that everything we do is kind of focused on our organic growth strategy, as we've talked about before, but that from time to time, it does make sense to buy when we think there's certain assets on the market that can give us a quicker entry point. Technology is often an area where we see that opportunity, and to the extent that we see those opportunities, We feel very comfortable with our leverage, very comfortable with our cash flow to be able to execute on those and make sure we're bringing the talent into the organization that we need to in order to execute on our strategy.
spk05: Okay, great. Thanks for taking the questions. Appreciate it.
spk01: Our next question comes from Josh Vogel of Sidoti. Please proceed, sir.
spk04: Thank you. Good afternoon, guys. A lot of my questions were covered, but maybe there's just another way to frame the pipeline of visibility conversation. You're seeing increases in the sales pipeline and the pace of signings in healthcare and education, but also a sales cycle that remains somewhat elongated. And I'm just curious, given the recent conversions, does that imply there's been some easing there relative to last year? And do you think that the cycle back to pre-pandemic cycles by the second half of the year, or perhaps even quicker, given how long clients were kind of, you know, sitting on their hands and maybe looking to rapidly reengage?
spk02: Josh, this is Jim. I'll start there. I think the thing that we saw probably more deferred than anything, there's probably two areas. One of them would be in healthcare and some of the performance improvement areas, again, deferred while we were going through the worst of the pandemic. And in education, the thing that got the most deferred was the larger ERP projects. And as we've described, I think in both cases, healthcare and education, you've seen the environment transition quite a bit. I just think it was really hard to undertake for our clients, really hard to undertake those kind of large projects at a point in time when they weren't sure about their financial stability. They weren't sure about the bandwidth of their own people to take it on. And acknowledge that a lot of it would probably have to be done remotely. You put it all together. And I think a lot of them just sorted through and said, you know what, this is urgent, but it's not that urgent. Let's wait a little bit. That's what's kind of picking up right now. I think in the case of the larger systems projects, you know, there's a pretty high degree of coordination that needs to take place at our clients. Forget about us. It's our clients just to get these things effective. It's not like we come in and do everything. They've got to play a major role in it. And so I think you're seeing some of those as they kind of regroup themselves. They're getting back to the point where they can envision taking on those more complicated projects. The same thing I think is happening in health care right now when I talked to somebody today who basically said that, you know, the current year financials are actually going to look pretty good because the biggest hit we took was probably in the prior fiscal year. but we're worried a lot more about the cost structure, uh, uh, in the, in the coming years. And that's, what's forcing them to go back and begin to think through how do they, how do they reposition their business to be successful, uh, in the future? So I think, I think this was just a, you know, it was to us, it was really easy to understand why these delays were taking place. But I think a lot of those reasons are now dissipating and we're now beginning to see things open up and people are more capable of addressing the, uh, their future. And that, I think, is why we're seeing a pickup in the size and complexity and visibility into our pipeline.
spk04: That's good insights there. Thank you. The hiring of the 300 FTEs, I think Johnny said it would add about $10 million to revenue. Is that all going to be in Q2?
spk03: No, no. That's for the remaining nine months of the year, Josh.
spk04: Okay. And I'm just thinking, you know, you hired these FTEs, they were targeted specifically for this project. Do you think there's an opportunity, though, to perhaps keep these people on your bench when the project is over, hoping that you can deploy them to other engagements, considering how the pipeline is building?
spk03: Josh, yeah, just to clarify on that point. So they actually weren't hired for any specific project. They really are They really were brought on to broaden our capabilities from a managed services perspective. And they are going to be able to be deployed on some of the opportunities that we had in our pipeline before we acquired them, as well as some specific work related to them. So absolutely, the plan is to build around this team and to continue to build out build out these capabilities. We expect the team to grow, quite frankly. So based on the demand that we see in the market, we think that there's going to be a lot of opportunity for these employees to help serve our clients. And that when we start to look forward to 2022, we actually think this is going to be an area that's going to help drive organic growth within this business and that these employees will be a key part of that.
spk04: Understood. I appreciate the clarification around that. And just one last one. You know, a lot of talk out there about an unprecedented and overwhelming wave of applications at colleges, you know, especially as some have waived the SATs and ACTs. And I was just curious, is that a potential tailwind for your business?
spk02: I don't think so, Josh. I mean, I think that's just, you know, first of all, it's not clear to me that the number of seats for all those applicants has really changed. And therefore, I think you may have a lot more applicants, but it doesn't necessarily transition more revenue. It certainly is not a headwind, but I don't think it's going to be a tailwind either. I think there's just kind of an anomaly where we're at right now, where everyone's just trying to do the best they can to get in because there's so many uncertainties in terms of who's going to go back to campus. The higher branded places will have no problem, but everyone's thinking, I think, that maybe I can apply to a place that I otherwise might not be able to get into because of all the disruptions taking place, and time will tell whether that happens or not. But I don't think it's going to be that much of a differentiator. I think it's just going to be an odd statistic that sits out there for a while.
spk04: I got you. Okay, great. Well, thanks for taking my questions.
spk01: Our next question comes from Toby Sommer of TruList Securities. Please proceed, sir.
spk07: I have a question for you on the education space. If President Biden's initiative to make community college and change some things in terms of education, making that free. What would those things that are on the table do for demand for your services, do you think?
spk02: Toby, I think it remains to see what's going to happen there. I would not anticipate that having a big impact on our core client base, which is certainly the largest research universities and also maybe the top 200 or 300 universities you know, ranked institutions. I think it has a big impact for people wanting to get an education that might not be able to afford to do it. But I don't think it's going to have a big impact in our business. Okay.
spk07: Thank you very much.
spk01: Seeing no more questions in the queue, I'd like to turn the call back over to Mr. Roth.
spk02: Thank you all for spending time with us this afternoon. We look forward to speaking with you again in July when we announce our second quarter results. Have a good evening.
Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-